BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31908230)

  • 1. Response to Neoadjuvant Treatment Is Influenced by Grade in Gastric Cancer.
    Kwong MLM; Denham L; Selleck MJ; Kim C; Kunihira K; Kubba R; Rojas R; Garberoglio C; Senthil M
    Am Surg; 2019 Dec; 85(12):1419-1422. PubMed ID: 31908230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
    Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
    Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients--does it improve survival?
    Saedi HS; Mansour-Ghanaei F; Joukar F; Shafaghi A; Shahidsales S; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2014; 15(20):8667-71. PubMed ID: 25374187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
    Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience.
    Ceniceros L; Chopitea A; Pardo F; Rotellar F; Arbea L; Sola JJ; Subtil JC; Sangro B; Benito A; Hernández-Lizoain JL; Rodríguez J
    Clin Transl Oncol; 2018 May; 20(5):658-665. PubMed ID: 29043568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
    Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy.
    Valenti V; Hernandez-Lizoaín JL; Beorlegui MC; Diaz-Gozalez JA; Regueira FM; Rodriguez JJ; Viudez A; Sola I; Cienfuegos JA
    J Surg Oncol; 2011 Aug; 104(2):124-9. PubMed ID: 21509785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
    Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
    J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
    Charalampakis N; Nogueras González GM; Elimova E; Wadhwa R; Shiozaki H; Shimodaira Y; Blum MA; Rogers JE; Harada K; Matamoros A; Sagebiel T; Das P; Minsky BD; Lee JH; Weston B; Bhutani MS; Estrella JS; Badgwell BD; Ajani JA
    Oncology; 2016; 90(5):239-47. PubMed ID: 27046280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
    Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
    Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
    Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
    Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
    Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review.
    Neves Filho EH; de Sant'Ana RO; Nunes LV; Pires AP; da Cunha MD
    APMIS; 2017 Feb; 125(2):79-84. PubMed ID: 28044374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.